Independence of, and interactions between, cannabinoid and opioid signal transduction pathways in N18TG2 cells

Brain Research

Volumn 806, Issue 1, 1998, Pages 26-35

  Shapira, Ma'anit ^a   Gafni, Mikhal ^a   Sarne, Yosef ^a  

^a Mauerberger Chair Neuropharmacology   (Israel)

Author keywords

Adenylyl cyclase; Cannabinoid receptor; Desensitization; GTP binding protein; Opioid receptor; Pertussis toxin

Indexed keywords

ADENYLATE CYCLASE; CANNABINOID RECEPTOR; CANNABINOID RECEPTOR AGONIST; DEACETYLLEVONANTRADOL; ETORPHINE; GUANINE NUCLEOTIDE BINDING PROTEIN; OPIATE AGONIST; OPIATE RECEPTOR; PERTUSSIS TOXIN;

ANIMAL CELL; ARTICLE; CELL LINE; DRUG INTERACTION; LONG TERM EXPOSURE; MEMBRANE BINDING; MODEL; NEUROBLASTOMA CELL; NONHUMAN; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; SIGNAL TRANSDUCTION;

ADENYLATE CYCLASE TOXIN; ANIMALS; CYCLIC AMP; DRUG INTERACTIONS; ETORPHINE; GTP-BINDING PROTEINS; GUANOSINE 5'-O-(3-THIOTRIPHOSPHATE); MICE; NARCOTICS; PERTUSSIS TOXIN; PHENANTHRIDINES; RECEPTORS, CANNABINOID; RECEPTORS, DRUG; RECEPTORS, OPIOID; SIGNAL TRANSDUCTION; TIME FACTORS; TUMOR CELLS, CULTURED; VIRULENCE FACTORS, BORDETELLA;

EID: 0032556059     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(98)00697-0     Document Type: Article

References (40)

1. Abood M.A., Ditto K.E., Noel A., Showalter V.M., Tao Q. Isolation and expression of a mouse CB1 cannabinoid receptor gene. Comparison of binding properties with those of native CB1 receptors in mouse brain and N18TG2 neuroblastoma cells. Biochem. Pharmacol. 53:1997;207-214.
2. Ammer H., Schulz R. Coupling of prostaglandin E1 receptors to the stimulatory GTP-binding protein Gs is enhanced in neuroblastoma×glioma (NG108-15) hybrid cells chronically exposed to an opioid. Mol. Pharmacol. 43:1993;556-563.
3. 1 subunit of GTP-binding proteins. J. Neurochem. 53:1989;1636-1639.
4. Baumhaker Y., Gafni M., Keren O., Sarne Y. Selective and interactive down-regulation of μ- and δ-opioid receptors in human neuroblastoma SK-N-SH cells. Mol. Pharmacol. 44:1993;461-467.
5. Baumhaker Y., Ben-Dor T., Bar-Hamburger R., Sarne Y. Characterization of triple opioid system in the human neuroblastoma NMB cell line. Brain Res. 665:1994;94-100.
6. 9-tetrahydrocannabinol in the mouse. Psychopharmacology. 57:1978;243-248.
7. Breivogel C.S., Selley D.E., Childers S.R. Acute and chronic effects of opioids on δ and μ receptors activation of G-proteins in NG108-15 and SK-N-SH cell membranes. J. Neurochem. 68:1997;1462-1472.
8. Carter B.D., Medzihradsky F. Receptor mechanism of opioid tolerance in SH-SY5Y human neural cells. Mol. Pharmacol. 43:1993;465-473.
9. Childers S.R. Opioid receptor-coupled second messenger systems. Life Sci. 48:1991;1991-2003.
10. A Devane W., Spain J.W., Coscia C.J., Howlett A.C. An assessment of the role of opioid receptors in the response to cannabimimetic drugs. J. Neurochem. 46:1986;1929-1935.
11. Dill J.A., Howlett A.C. Regulation of adenylate cyclase by chronic exposure to cannabimimetic drugs. J. Pharmacol. Exp. Ther. 244:1988;1157-1163.
12. 2-adrenergic, muscarinic, and opiate receptors. Mol. Pharmacol. 43:1992;434-443.
13. Hilf G., Gierschik P., Jakobs K.H. Muscarinic acetylcholine receptor-stimulated binding of guanosine-5′-O-(3-thiotriphosphate) to guanine nucleotide-binding proteins in cardiac membranes. Eur. J. Biochem. 186:1989;725-731.
14. Hine B., Friedman E., Torrelio M., Gershon S. Morphine-dependent rats: blockade of precipitated abstinence by tetrahydrocannabinol. Science. 187:1975;443-445.
15. 9-tetrahydrocannabinol: two-way cross tolerance for antinociceptive and heart-rate responses in the rat. Psychopharmacology. 87:1985;34-38.
16. Howlett A.C., Qualy J.M., Khachatrian L.L. Involvement of Gi in the inhibition of adenylate cyclase by cannabimimetic drugs. Mol. Pharmacol. 29:1985;307-313.
17. A.C. Howlett, Cannabinoid compounds and signal transduction mechanisms, in: R.G. Pertwee (Ed.), Cannabinoid receptors, Academic Press, 1995, pp. 169-204.
18. 9-tetrahydrocannabinol-tolerant rats. Psychopharmacology. 55:1977;243-249.
19. 9-THC on hypothalamic luteinizing hormone releasing hormone and met-enkephalin content and serum levels of testosterone and corticosterone in rats. Subst. Alch. Act. Misuse. 4:1983;37-43.
20. Law P.Y., Koehler J.E., Loh H.H. Comparison of opiate inhibition of adenylate cyclase activity in neuroblastoma N18TG2 and neuroblastoma×glioma NG108-15 hybrid cell lines. Mol. Pharmacol. 21:1982;483-491.
21. Pacheco M.A., Ward S.J., Childers S.R. Identification of cannabinoid receptors in cultures of rat cerebellum granule cells. Brain Res. 603:1992;102-110.
22. Pugh G., David D.J., Combs V., Welch S.P. Involvement of dynorphine B in the antinociceptive effects of the cannabinoid CP55,940 in the spinal cord. J. Pharmacol. Exp. Ther. 281:1997;730-737.
23. 9-THC in the spinal cord. Brain Res. 689:1995;157-158.
24. 9-tetrahydrocannabinol-induced analgesia in mice. Eur. J. Pharmacol. 301:1996;75-81.
25. Rubino T., Patrini G., Parenti M., Massi P., Parolaro D. Chronic treatment with a synthetic cannabinoid CP-55,940 alters G-protein expression in the rat central nervous system. Mol. Brain Res. 44:1997;191-197.
26. Y. Salomon, Adenylate cyclase assay, in: G. Brooker et al. (Eds.), Advances in Cyclic Nucleotide Research, Vol. 10, Raven Press, New York, 1979, pp. 35-55.
27. 3H ]cAMP in cell monolayers, cell suspensions and tissue slices Methods Enzymol. 195:1991;22-28.
28. Selley D.E., Nestler E.J., Breivogel C.S., Childers S.R. Opioid receptor-coupled G-proteins in rat locus coeruleus membranes: decrease in activity after chronic morphine treatment. Brain Res. 746:1997;10-18.
29. Sharma S.K., Klee W.A., Nirenberg M. Dual regulation of adenylate cyclase accounts for narcotic dependence and tolerance. Proc. Natl. Acad. Sci. U.S.A. 72:1975;3092-3096.
30. 35S ]thio)triphosphate binding Neurobiology. 92:1995;7242-7246.
31. Sim L.J., Selley D.E., Xiao R., Childers S.R. Differences in G-protein activation by μ- and δ-opioid, and cannabinoid, receptors in rat striatum. Eur. J. Pharmacol. 307:1996;97-105.
32. 35S ]GTPγS autoradiography in rat brain J. Neurosci. 16:1996;8057-8066.
33. Standifer K.M., Pasternak G.W. G-proteins and opioid receptor-mediated signalling. Cell. Signal. 9:1997;237-248.
34. 1 opioid receptor mechanism. Science. 276:1997;2048-2050.
35. 35S ]thio)triphosphate binding to membranes from human neuroblastoma SH-SY5Y cells Mol. Pharmacol. 47:1995;848-854.
36. 9-tetrahydrocannabinol in rats. Eur. J. Pharmacol. 70:1981;219-224.
37. 9-THC) leads to changes in opioid-related behavioural patterns in rats. Brain Res. 680:1995;142-147.
38. Vela G., Ruiz-Gayo M., Fuentes J.A. Anandamide decreases naloxone-precipitated withdrawal signs in mice chronically treated with morphine. Neuropharmacology. 34:1995;665-668.
39. Welch S.P., Thomas C., Patrick G.S. Modulation of cannabinoid-induced antinociception after intracerebroventricular versus intrathecal administration to mice: possible mechanisms for interaction with morphine. J. Pharmacol. Exp. Ther. 272:1995;310-321.
40. Wilson R.S., May E.L. Analgesic properties of the tetrahydrocannabinols, their metabolites and analogs. J. Med. Chem. 18:1975;700-703.